Cover Image
Market Research Report

Global Oxidative Stress Assay Market for Pharmaceutical Industry 2018-2022

Published by TechNavio (Infiniti Research Ltd.) Product code 635740
Published Content info 112 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Oxidative Stress Assay Market for Pharmaceutical Industry 2018-2022
Published: May 2, 2018 Content info: 112 Pages
Description

About Oxidative Stress Assay for Pharmaceutical Industry

Oxidative stress assay is conducted to analyze free radicals in a cell, which can interfere with cellular metabolism. This test is conducted using various products such as consumables and is used by end-users such as pharmaceutical research centers and companies.

Technavio's analysts forecast the global oxidative stress assay market for pharmaceutical industry to grow at a CAGR of 8.36% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global oxidative stress assay market for pharmaceutical industry for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Oxidative Stress Assay Market for Pharmaceutical Industry 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abcam
  • Merck
  • Promega Corporation
  • QIAGEN
  • Thermo Fisher Scientific

Market driver

  • Increasing investments in drug discovery
  • For a full, detailed list, view our report

Market challenge

  • Lack of skilled professionals
  • For a full, detailed list, view our report

Market trend

  • Outsourcing drug discovery processes
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents
Product Code: IRTNTR21735

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Segmentation by product
  • Comparison by product
  • Consumables
  • Instruments
  • Services
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Increased adoption of precision medicine
  • Outsourcing drug discovery process
  • Growing focus on promotional activities

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abcam
  • Merck
  • Promega Corporation
  • QIAGEN
  • Thermo Fisher Scientific

PART 15: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Parent market
  • Exhibit 02: Global oxidative stress assay market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 09: Global - Year over year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces
  • Exhibit 18: Product - Market share 2017-2022 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Consumables - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 21: Consumables - Year-over-year growth 2018-2022 (%)
  • Exhibit 22: Instruments - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 23: Instruments - Year-over-year growth 2018-2022 (%)
  • Exhibit 24: Services - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 25: Services - Year-over-year growth 2018-2022 (%)
  • Exhibit 26: Market opportunity by product
  • Exhibit 27: Customer landscape
  • Exhibit 28: Global - Market share by geography 2017-2022 (%)
  • Exhibit 29: Regional comparison
  • Exhibit 30: Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 31: Americas - Year-over-year growth 2018-2022 (%)
  • Exhibit 32: Top 3 countries in Americas
  • Exhibit 33: APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 34: APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 35: Top 3 countries in APAC
  • Exhibit 36: EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 37: EMEA - Year over year growth 2018-2022 (%)
  • Exhibit 38: Top 3 countries in EMEA
  • Exhibit 39: Market opportunity
  • Exhibit 40: Vendor landscape
  • Exhibit 41: Landscape disruption
  • Exhibit 42: Vendors covered
  • Exhibit 43: Vendor classification
  • Exhibit 44: Market positioning of vendors
  • Exhibit 45: Vendor overview
  • Exhibit 46: Abcam - Business segments
  • Exhibit 47: Abcam - Organizational developments
  • Exhibit 48: Abcam - Geographic focus
  • Exhibit 49: Abcam- Segment focus
  • Exhibit 50: Abcam- Key offerings
  • Exhibit 51: Vendor overview
  • Exhibit 52: Merck - Business segments
  • Exhibit 53: Merck - Organizational developments
  • Exhibit 54: Merck - Geographic focus
  • Exhibit 55: Merck- Segment focus
  • Exhibit 56: Merck - Key offerings
  • Exhibit 57: Vendor overview
  • Exhibit 58: Promega Corporation - Business segments
  • Exhibit 59: Promega Corporation - Organizational developments
  • Exhibit 60: Promega Corporation - Geographic focus
  • Exhibit 61: Promega Corporation - Segment focus
  • Exhibit 62: Promega Corporation - Key offerings
  • Exhibit 63: Vendor overview
  • Exhibit 64: QIAGEN - Business segments
  • Exhibit 65: QIAGEN - Organizational developments
  • Exhibit 66: QIAGEN - Geographic focus
  • Exhibit 67: QIAGEN - Segment focus
  • Exhibit 68: QIAGEN - Key offerings
  • Exhibit 69: Vendor overview
  • Exhibit 70: Thermo Fisher Scientific - Business segments
  • Exhibit 71: Thermo Fisher Scientific- Organizational developments
  • Exhibit 72: Thermo Fisher Scientific - Geographic focus
  • Exhibit 73: Thermo Fisher Scientific- Segment focus
  • Exhibit 74: Thermo Fisher Scientific- Key offerings
Back to Top